Whitepapers/App Notes/Posters

Scientific poster: Advantage of antibody based selectivity in the purification of biologics

Posted: 26 June 2019 | | No comments yet

ADVANCES in biotherapeutics are generating an increasing range of complex molecules that present unique and often complex purification challenges.

By taking advantage of antibody based selectivity, Camelid heavy-chain antibody fragments (VHHs) have proven to be a reliable immunoaffinity  chromatography (IAC) solution in the downstream process of biologics. ThermoScientific™ CaptureSelect™ affinity products and analytical tools are developed for the discovery and manufacturing of even the most demanding biotherapeutics.











To read this scientific poster in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsors: Thermo Fisher Scientific

Send this to a friend